Abiopharma

New Form 8-K - PharmaCyte Biotech, Inc. Filed: 2025-08-18 AccNo: 0001683168-25-006274 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits